Two‐year outcome of ventricular assist device via a modified left atrium to aorta approach in cardiac amyloidosis

Two‐year outcome of ventricular assist device via a modified left atrium to aorta approach in cardiac amyloidosis

Abstract Cardiac amyloidosis is a debilitating disease associated with poor long‐term survival. Medical or palliative treatment is the usual course of therapy, but patients are often intolerant of conventional heart failure treatment. The current standard of care of sequential heart and bone marrow...

Full description

Bibliographic Details
Main Authors: Choon Pin Lim, Yeong Phang Lim, Chong Hee Lim, Hean‐Yee Ong, Daryl Tan, Abdul Razakjr Omar
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:ESC Heart Failure
Subjects:
LVAD
Ventricular assist device
Cardiac amyloidosis
Amyloid cardiomyopathy
Daratumumab
Heart failure
Online Access:https://doi.org/10.1002/ehf2.14039

Internet

https://doi.org/10.1002/ehf2.14039

Similar Items